1. Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes
   Lu Xing et al, 2022, Frontiers in Pharmacology CrossRef
2. Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications
   Mohammad Asad et al, 2019, Current Cancer Drug Targets CrossRef
3. Prognostic analysis of patients with gastric cancer based on N6-methyladenosine modification patterns and tumor microenvironment characterization
   Miaomiao Huo et al, 2024, Frontiers in Pharmacology CrossRef
4. Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
   Tao Zhang et al, 2021, Frontiers in Oncology CrossRef
5. High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma
   Min Cai et al, 2021, Pathology and Oncology Research CrossRef
6. Epitope Peptides Vaccine for Colorectal Cancer -the Present Status and the Prospects-
   Shoichi Hazama et al, 2012, Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) CrossRef
7. ANTI-TUMOR IMMUNE RESPONSES INDUCED BY RADIOTHERAPY: A REVIEW
   YUYA YOSHIMOTO et al, 2015, FUKUSHIMA JOURNAL OF MEDICAL SCIENCE CrossRef
8. TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer
   Zhigui Li et al, 2023, Frontiers in Oncology CrossRef